Participate in design of clinical trial for an IBS pain medication
Posted 30 November 2018 - 09:02 AM
We would like to invite members of the IBS Group to an opportunity to participate in the design of a clinical trial for a new non-opioid analgesic (pain medication) to treat IBS pain. The design of the clinical trial is being developed by Transparency Life Sciences (TLS), a digital clinical trial services company.
TLS wants to engage patients in the design of the trial which will encourage greater patient participation and lead to enhanced patient satisfaction. Please click the link below to be directed to the TLS Protocol Builder.
Click "Start Protocol Builder Now" when a new page opens after clicking the link.